Compare UBER & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UBER | MDT |
|---|---|---|
| Founded | 2009 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.0B | 131.9B |
| IPO Year | 2019 | 2014 |
| Metric | UBER | MDT |
|---|---|---|
| Price | $73.84 | $91.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 34 | 19 |
| Target Price | $106.30 | ★ $109.82 |
| AVG Volume (30 Days) | ★ 18.7M | 8.0M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | ★ 3.12% |
| EPS Growth | 3.73 | ★ 30.80 |
| EPS | ★ 4.73 | 2.76 |
| Revenue | ★ $52,017,000,000.00 | $33,537,000,000.00 |
| Revenue This Year | $14.30 | $8.91 |
| Revenue Next Year | $14.36 | $6.75 |
| P/E Ratio | ★ $15.85 | $32.90 |
| Revenue Growth | ★ 18.28 | 3.62 |
| 52 Week Low | $60.63 | $79.55 |
| 52 Week High | $101.99 | $106.33 |
| Indicator | UBER | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 29.39 |
| Support Level | $69.02 | $88.29 |
| Resistance Level | $93.58 | $93.13 |
| Average True Range (ATR) | 2.41 | 1.92 |
| MACD | 0.58 | -0.76 |
| Stochastic Oscillator | 45.73 | 12.99 |
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 202 million users who order rides or food at least once a month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.